Huntington’s Disease
Contributing to the understanding of Huntington’s disease.
Looking for a technology or invention to commercialise?
Whether it's creating a spin-out, licensing a technology or invention, copyright, database rights or confidential know-how.
King's has a large array of cutting-edge technologies and inventions created by our world-class academics that can be searched and licensed.
Our IP & Licensing experts work closely with external partners and our academic inventors to ensure that the commercialisation process is appropriate and timely.
King's is supportive of the recommendations made in the recent Independent Review of University Spin-out Companies. We have substantively adopted these, working towards full adoption. Further details can be found in our updated Intellectual Property, Commercial Exploitation & Financial Benefits Code of Practice.
Find out more about our available technologies.
For advice on how to work with us, as well as general enquiries about licensing, new spinout company opportunities and post-formation support, please contact innovation@kcl.ac.uk.
Mike heads up the team with responsibility for all aspects of management of the King’s IP as well as the development of new spin-out company opportunities and post-formation support.
Rachel is responsible for the administration of the King's intellectual property portfolio.
This includes the provision of paralegal support to Ceri Matthews, Pushkar Wadke and Lorenza Grechy and the development and maintenance of related database records and reports.
Monique is responsible for the administration of the King's intellectual property portfolio. This includes the provision of paralegal support to Salma Ishaq and Nathalie John and the development and maintenance of related database records and reports.
Janet is responsible for the administration of the King's intellectual property portfolio. This includes the provision of paralegal support to Melissa Rubock and Ian Durrant and the development and maintenance of related database records and reports.
Contributing to the understanding of Huntington’s disease.
The UCOE (Ubiquitous Chromatin Opening Element) technology, developed at...
Collaborating to advance tissue-derived gamma delta (γδ) T cells.